Name: CRYBA1 | Sequence: fasta or formatted (215aa) | NCBI GI: 12056461 | |
Description: crystallin, beta A3
|
Referenced in: Crystallins and Other Eye Proteins
| ||
Composition:
Amino acid Percentage Count Longest homopolymer A alanine 4.2 9 1 C cysteine 2.3 5 1 D aspartate 3.3 7 2 E glutamate 8.8 19 1 F phenylalanine 4.2 9 1 G glycine 7.9 17 2 H histidine 3.3 7 2 I isoleucine 6.5 14 1 K lysine 4.2 9 1 L leucine 3.7 8 1 M methionine 3.3 7 1 N asparagine 4.2 9 2 P proline 4.2 9 1 Q glutamine 8.4 18 2 R arginine 5.6 12 2 S serine 9.3 20 2 T threonine 5.1 11 2 V valine 2.3 5 1 W tryptophan 4.2 9 1 Y tyrosine 5.1 11 1 |
Comparative genomics:
Search single species RefSeq proteins at NCBI
Search summary
Figure data | ||
Related human proteins:Protein Relative score Description Self-match 1.000 crystallin, beta A3 CRYBA4 0.625 crystallin, beta A4 CRYBA2 0.477 crystallin, beta A2 CRYBA2 0.477 crystallin, beta A2 CRYBA2 0.477 crystallin, beta A2 CRYBB1 0.389 crystallin, beta B1 CRYBB3 0.330 crystallin, beta B3 CRYBB2 0.320 crystallin, beta B2 CRYGS 0.214 crystallin, gamma S CRYGC 0.211 crystallin, gamma C CRYGB 0.202 crystallin, gamma B CRYGA 0.182 crystallin, gamma A CRYGD 0.180 crystallin, gamma D CRYGN 0.177 gammaN-crystallin AIM1L 0.161 absent in melanoma 1-like CRYBG3 0.157 beta-gamma crystallin domain containing 3 AIM1 0.157 absent in melanoma 1 LOC100287598 0.009 PREDICTED: hypothetical protein XP_002343488 NSD1 0.007 nuclear receptor binding SET domain protein 1 isofor... SS18L1 0.007 SS18-like protein 1Human BLASTP results (used to prepare the table) |
Gene descriptions are from NCBI RefSeq. Search results were obtained with NCBI BLAST and RefSeq entries. When identical proteins are present, the self-match may not be listed first in BLASTP output. In such cases, the table above has been reordered to place it first.
See About the Figures for the scoring system used in the figure above right. The same scoring system was used in the table of BLASTP results.
Guide to the Human Genome
Copyright © 2010 by Stewart Scherer. All rights reserved.